IR@PKUHSC  > 北京大学第一临床医学院
学科主题临床医学
Neoadjuvant Chemotherapy Is Associated With Prolonged Primary Treatment Intervals in Patients With Advanced Epithelial Ovarian Cancer
Milam, Michael R.1; Tao, Xia2; Coleman, Robert L.3; Harrell, Robyn4; Bassett, Roland5; dos Reis, Ricardo5; Ramirez, Pedro T.3
关键词Neoadjuvant chemotherapy Ovarian cancer
刊名INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2011
DOI10.1097/IGC.0b013e3182013e2f
21期:1页:66-71
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Obstetrics & Gynecology
研究领域[WOS]Oncology ; Obstetrics & Gynecology
关键词[WOS]HYPERSENSITIVITY REACTIONS ; SURGICAL CYTOREDUCTION ; DEBULKING SURGERY ; CARCINOMA ; SURVIVAL ; MANAGEMENT
英文摘要

Background: We evaluated the impact of neoadjuvant chemotherapy (NC) relative to primary surgery (PS) to determine if there was a difference in the total time and number of chemotherapy cycles given in patients with advanced epithelial ovarian cancer.

Methods: We identified 263 consecutive women meeting eligibility from 1993 to 2005 for this institutional review board-approved study. Eligible patients in this analysis were those women with advanced disease (stage IIIC-IV) in whom a maximal cytoreductive effort was planned either at PS or after NC. Time to start chemotherapy was defined as follows: (1) NC group: confirmation of diagnosis through biopsy, cytological diagnosis from ascites, and pleural effusion; (2) PS group: confirmation of diagnosis from the date of surgery that confirmed the diagnosis of epithelial ovarian cancer. Total chemotherapy cycles: (1) NC group: NC chemotherapy cycles plus postoperative cycles; (2) PS group: chemotherapy after primary tumor debulking surgery. Clinical information evaluated included chemotherapy type, chemotherapy cycle number, total time to administer frontline chemotherapy, and survival.

Results: Median chemotherapy cycles were greater in the NC group compared with the PS group (9 [range, 4-30] vs 6 [range, 3-19]; P < 0.01). The PS group was also more likely to undergo chemotherapy regimens involving platinum and taxane treatment compared with the NC group (79% vs 65%; P = 0.017). Total time undergoing primary chemotherapy from initial diagnosis was greater in the NC group compared with PS (223 vs 151 days; P < 0.01). No significant difference was observed in overall survival and progression-free survival in the 2 groups.

Conclusions: In patients with advanced ovarian cancer, NC followed by abdominal hysterectomy is associated with improved perioperative outcomes including optimal cytoreduction, decreased blood loss, and decreased inpatient hospitalization. In this cohort, NC was also associated with prolonged chemotherapy treatment intervals and increased chemotherapy cycles without improvement in survival.

语种英语
WOS记录号WOS:000285582500011
引用统计
被引频次:12[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66332
专题北京大学第一临床医学院
北京大学第一临床医学院_妇产科
作者单位1.Univ Louisville, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol,J Brown Canc Ctr, Louisville, KY 40202 USA
2.Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China
3.Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
4.Univ Fed Rio Grande do Sul, Gynecol Oncol Serv, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
5.Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
推荐引用方式
GB/T 7714
Milam, Michael R.,Tao, Xia,Coleman, Robert L.,et al. Neoadjuvant Chemotherapy Is Associated With Prolonged Primary Treatment Intervals in Patients With Advanced Epithelial Ovarian Cancer[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER,2011,21(1):66-71.
APA Milam, Michael R..,Tao, Xia.,Coleman, Robert L..,Harrell, Robyn.,Bassett, Roland.,...&Ramirez, Pedro T..(2011).Neoadjuvant Chemotherapy Is Associated With Prolonged Primary Treatment Intervals in Patients With Advanced Epithelial Ovarian Cancer.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER,21(1),66-71.
MLA Milam, Michael R.,et al."Neoadjuvant Chemotherapy Is Associated With Prolonged Primary Treatment Intervals in Patients With Advanced Epithelial Ovarian Cancer".INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 21.1(2011):66-71.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Milam, Michael R.]的文章
[Tao, Xia]的文章
[Coleman, Robert L.]的文章
百度学术
百度学术中相似的文章
[Milam, Michael R.]的文章
[Tao, Xia]的文章
[Coleman, Robert L.]的文章
必应学术
必应学术中相似的文章
[Milam, Michael R.]的文章
[Tao, Xia]的文章
[Coleman, Robert L.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。